Cardinal Health, Inc. (CAH)

US — Healthcare Sector
Peers: ABC  HSIC  OMI  PDCO  MCK  ZYXI  EDAP 

Automate Your Wheel Strategy on CAH

With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CAH
  • Rev/Share 926.1917
  • Book/Share -7.9083
  • PB -13.0681
  • Debt/Equity -2.6048
  • CurrentRatio 0.9436
  • ROIC 0.1279

 

  • MktCap 38312432040.0
  • FreeCF/Share 10.1625
  • PFCF 15.7083
  • PE 24.7271
  • Debt/Assets 0.154
  • DivYield 0.0126
  • ROE -0.5014

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 2
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade CAH Wells Fargo Equal Weight Overweight -- $179 June 3, 2025
Upgrade CAH Jefferies Hold Buy $140 $150 Feb. 5, 2025
Upgrade CAH TD Cowen Hold Buy $130 $144 Jan. 8, 2025
Upgrade CAH Evercore ISI In-line Outperform -- $140 Jan. 7, 2025
Upgrade CAH BofA Securities Neutral Buy $132 $145 Jan. 6, 2025
Upgrade CAH Wells Fargo Underweight Equal Weight $101 $127 Dec. 13, 2024
Resumed CAH Mizuho -- Outperform -- $139 Dec. 4, 2024

News

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
CAH
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
CAH
Published: March 25, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Read More
image for news Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
Cardinal Health, Inc. (CAH) Leerink's 2025 Global Healthcare Conference (Transcript)
CAH
Published: March 12, 2025 by: Seeking Alpha
Sentiment: Neutral

Cardinal Health, Inc. (NYSE:CAH ) Leerink's 2025 Global Healthcare Conference Call March 12, 2025 8:40 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Investor Relations Conference Call Participants Mike Cherny - Leerink Mike Cherny Perfect. We'll get started here.

Read More
image for news Cardinal Health, Inc. (CAH) Leerink's 2025 Global Healthcare Conference (Transcript)
5 Broker-Loved Stocks to Keep an Eye on After Recent Analyst Upgrades
ABM, CAH, CWH, DAN, DXC
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors should monitor stocks like Dana, Camping World, ABM, Cardinal Health and DXC for high returns.

Read More
image for news 5 Broker-Loved Stocks to Keep an Eye on After Recent Analyst Upgrades

About Cardinal Health, Inc. (CAH)

  • IPO Date 1983-08-04
  • Website https://www.cardinalhealth.com
  • Industry Medical - Distribution
  • CEO Mr. Jason M. Hollar
  • Employees 47922

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.